In a follow-up study, the authors used immunodeficient NLGN3 knockout mice bearing xenografts of patient-derived HGG cells to show that, in the absence of NLGN3, tumor growth was almost completely inhibited over a protracted observation period of 6 months (Venkatesh and others 2017). This evidence concerns the gene NLGN3 and neoplasm.